New antibody tested in healthy volunteers – no cure yet
Knowledge-focused
Completed
This early-stage study tested a single dose of the experimental antibody SM17 in 30 healthy Chinese adults to see if it is safe and how the body processes it. The study did not aim to treat any disease. Results will help plan future trials for conditions like eczema, asthma, and …
Phase: PHASE1 • Sponsor: SinoMab BioScience Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC